Lung Cancer
Conference Coverage
CBSM phone app eases anxiety, depression in cancer patients
Few patients with cancer have access to psycho-oncologic support.
Latest News
T-DXd active in many solid tumors; ‘shift in thinking’
T-DXd is a potential new treatment option for patients with HER2-expressing solid tumors, experts say.
News
Drugmakers are abandoning cheap generics, and now U.S. cancer patients can’t get meds
On Nov. 22, three FDA inspectors arrived at the sprawling Intas Pharmaceuticals plant south of Ahmedabad, India, and found hundreds of trash bags...
Conference Coverage
Reducing risk for thrombosis in patients with lung cancer
This risk may be increased by certain cancer drugs, which seems to be the case for the combination of innovative targeted therapies lazertinib-...
Latest News
Few of those eligible get lung cancer screening, despite USPSTF recommendations
Fewer than 13% who are eligible get CT screening. Results highlight the need for education, Medicare coverage, and recognition of stigma’s role,...
News
Electronic nose may sniff out early lung cancer in COPD
Molecular profiling of exhaled breath using electronic nose (eNose) technology has shown potential as a method of early detection by identifying...
Conference Coverage
ACS officer provides ASCO highlights: Targeting hidden cancer, AI in oncology
A pair of new studies show that drugs can reduce cancer risk when cells are elusive.
News
Widespread carboplatin, cisplatin shortages: NCCN survey
Only 64% of centers said they are still able to continue treating all current patients receiving carboplatin.
News
Safe to stop immunotherapy at 2 years in stable lung cancer
“These data may provide reassurance to us and patients that discontinuing treatment at 2 years can confer the same overall survival as extended...
Conference Coverage
SCLC: Bispecific antibody shows phase 1 promise
The antibody targets delta-like ligand 3, which is one of few surface markers for small cell lung cancer.